Wuhan Hvsen Biotechnology Stock Cash And Equivalents
| 300871 Stock | 11.40 0.01 0.09% |
Wuhan Hvsen Biotechnology fundamentals help investors to digest information that contributes to Wuhan Hvsen's financial success or failures. It also enables traders to predict the movement of Wuhan Stock. The fundamental analysis module provides a way to measure Wuhan Hvsen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Wuhan Hvsen stock.
Wuhan | Cash And Equivalents |
Wuhan Hvsen Biotechnology Company Cash And Equivalents Analysis
Wuhan Hvsen's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Wuhan Hvsen Biotechnology has 0.0 in Cash And Equivalents. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The cash and equivalents for all China stocks is 100.0% higher than that of the company.
Wuhan Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Wuhan Hvsen's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Wuhan Hvsen could also be used in its relative valuation, which is a method of valuing Wuhan Hvsen by comparing valuation metrics of similar companies.Wuhan Hvsen is currently under evaluation in cash and equivalents category among its peers.
Wuhan Fundamentals
| Return On Equity | -0.0312 | ||||
| Return On Asset | -0.0029 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 2.33 B | ||||
| Shares Outstanding | 165.77 M | ||||
| Shares Owned By Insiders | 60.51 % | ||||
| Shares Owned By Institutions | 3.84 % | ||||
| Price To Book | 1.33 X | ||||
| Price To Sales | 1.69 X | ||||
| Revenue | 1.02 B | ||||
| Gross Profit | 222.75 M | ||||
| EBITDA | 150.08 M | ||||
| Net Income | 16.78 M | ||||
| Total Debt | 240.32 M | ||||
| Book Value Per Share | 8.62 X | ||||
| Cash Flow From Operations | 92.92 M | ||||
| Earnings Per Share | (0.28) X | ||||
| Target Price | 17.89 | ||||
| Number Of Employees | 1.07 K | ||||
| Beta | 0.47 | ||||
| Market Capitalization | 1.89 B | ||||
| Total Asset | 2.98 B | ||||
| Retained Earnings | 341.94 M | ||||
| Working Capital | 484.9 M | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 2.98 B | ||||
| Last Dividend Paid | 0.27 |
About Wuhan Hvsen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Wuhan Hvsen Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Wuhan Hvsen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Wuhan Hvsen Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Wuhan Stock
Wuhan Hvsen financial ratios help investors to determine whether Wuhan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wuhan with respect to the benefits of owning Wuhan Hvsen security.